ALAMEDA, Calif. & WORCESTER, Mass.--(BUSINESS WIRE)--Feb. 7, 2006--Advanced Cell Technology, Inc. (OTCBB:ACTC) has announced today that it has opened a new 15,000 square foot state-of-the-art facility in Alameda, California that encompasses a 10,000 square foot Good Manufacturing Practice (GMP) capable laboratory. ACT’s operation of a laboratory capable of manufacturing clinical-grade product based on human embryonic stem cell technology demonstrates the company’s commitment to be a world leader in the development of new human therapies in the emerging field of regenerative medicine. In conjunction with the sublease, the company acquired cell culture and manufacturing equipment previously validated for use in the GMP manufacture of cell-based therapies.
